Welcome to ICOD Project.
Positive results with the clinical Phase 1/2 Study with AEF0217 in young adults with Down syndrome Our ICOD project at the European Parliament the 19th of March for the World Down Syndrome Day 2025 Horizon Magazine article published: Living longer, living better: new advances in Down syndrome care Aelis Farma has received a positive opinion from the EMA Pediatric Committee on the Pediatric Investigation Plan for AEF0217 in Down syndrome. Aelis Farma obtains regulatory approval for the Phase 2B trial of AEF0217 in people with Down syndromeSelect your language
